Althea Group Holdings Limited (ASX:AGH)

Market Cap	19.45M
Revenue (ttm)	27.98M
Net Income (ttm)	-16.96M
Shares Out	845.47M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,128,641
Average Volume	2,380,414
Open	0.0220
Previous Close	0.0220
Day's Range	0.0220 - 0.0230
52-Week Range	0.0170 - 0.0540
Beta	1.42
RSI	36.96
Earnings Date	Aug 28, 2025

About Accolade

Althea Group Holdings Limited manufactures, distributes, and sells cannabis-based medicines and recreational cannabis products in Australia, the United Kingdom, Canada, Germany, and Ireland. It also offers education, access, and management services to support eligible patients and healthcare professionals in navigating medicinal cannabis treatment pathways. In addition, the company provides formulation and manufacturing of recreational cannabis products, such as beverages, edibles, concentrates, and topicals; and owns and operates a private med...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2016
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: AGH

Financial Performance

In 2024, Althea Group Holdings's revenue was 30.37 million, an increase of 21.01% compared to the previous year's 25.09 million. Losses were -32.06 million, 133.6% more than in 2023.